Carboprost Tromethamine Market and Its Impact on Postpartum Hemorrhage Management
Postpartum hemorrhage remains a global health concern, and the Carboprost Tromethamine Market is central to its management. Carboprost, as a uterotonic drug, plays a life-saving role in controlling severe bleeding after childbirth.
Its inclusion in maternal healthcare guidelines has improved survival rates significantly. With more women giving birth in hospitals and clinics, carboprost use is becoming routine in obstetric practices worldwide.
Market Outlook: Valued at USD 1.6 billion in 2023, the market is projected to reach USD 2.09 billion by 2032, expanding at a 3.40% CAGR.